The use of a gestational surrogate (GS) for in vitro fertilization (IVF)
has become an accepted alternative for women who would otherwise
not be able to carry a pregnancy. “Full surrogacy” refers to the use of
the intended parents’ gametes to create embryos through IVF with subsequent
transfer to the GS, who thus contributes no genetic material to
the embryo. “Partial surrogacy” (commonly known as “traditional surrogacy”)
refers to the artificial insemination of the GS using the
intended father’s sperm,meaning that the GS contributes geneticmaterial
[1]. According to a survey by the International Federation of Fertility
Societies [2], 37% of respondent countries practice full surrogacy.
Although surrogacy remains controversial, there is a continued demand
for suitable GSs in both the non-commercial (European) and commercial
(US) settings [3,4].With the changing legislative climateworldwide,
the need for appropriate candidates could grow.
Gestational surrogacy represents a substantial commitment,
demanding psychological maturity and a healthy adjustment. The
European Society of Human Reproduction and Embryology Task Force
on Ethics and Law addressing surrogacy [1] has indicated that GS
candidates should be adequately counseled and carefully screened